|
Claims  |
|
|
We claim:
1. A percutaneous endocardial lead comprising:
an elongated body member having an elongated hollow core therewithin, a
proximal end portion, and a distal end portion;
an elongated shaft member slidingly mounted within said elongated hollow
core of the body member, said elongated shaft member having a proximal end
portion and a distal end portion, and said shaft member distal end portion
being operatively connected to said distal end portion of the elongated
body member;
a tip electrode at said distal end portion of the elongated shaft member
and in electrical communication with said proximal end portion of the
elongated body member;
a plurality of elongated peripheral segments at the distal end portion of
the elongated body member;
a plurality of elongated conductors, each extending between each of said
elongated peripheral segments and said proximal end portion of the
elongated body member, said elongated conductors being insulated from each
other;
mapping electrode means including a plurality of electrodes, each said
electrode being on each said elongated peripheral segment, each said
electrode being in electrical communication with one of said elongated
conductors, and said electrodes of the mapping electrode means provide an
electrode array generally around the tip electrode;
means for adjusting said electrode array between a closed configuration
that is substantially isodiametric with said elongated body member and
open configurations at which each elongated peripheral segment folds on
itself and moves each electrode to an outwardly directed location
including to a location generally coplanar with said tip electrode;
said means for adjusting said electrode array including said elongated body
member and said elongated shaft member slidingly mounted therewithin,
whereby said elongated body member and said elongated shaft slidingly move
relative to each other in order to adjust said electrode array between
said closed configuration and said open configurations; and
ablation means having an ablation surface generally at said tip electrode,
said ablation surface being generally circumscribed by said electrode
array at said open configurations thereof.
2. The percutaneous lead according to claim 1, wherein said distal end
portion of the elongated body member includes a plurality of elongated
slits that are spaced from each other along the circumference of said
distal end portion in order to define said elongated peripheral segments.
3. The percutaneous lead according to claim 1, further including a handle
assembly mounted onto said proximal end portion of the elongated shaft
member.
4. The percutaneous lead according to claim 1, further including a locking
assembly in order to secure a selected relative position of said elongated
body member with respect to said elongated shaft.
5. The percutaneous lead according to claim 1, wherein said elongated
conductor and said electrode are of a continuous unitary structure, and
said electrode is formed by passing a portion of said elongated conductor
through said elongated peripheral segment.
6. The percutaneous lead according to claim 1, wherein said elongated shaft
member is an electrical conductor.
7. The percutaneous lead according to claim 1, wherein said tip electrode
is operatively secured to said elongated shaft member, said elongated
shaft member providing electrical communication between the tip electrode
and the proximal end portion of the elongated body member.
8. The percutaneous lead according to claim 1, wherein said elongated shaft
member is an optical fiber having a distal end at which said ablation
surface is located.
9. The percutaneous lead according to claim 1, wherein said tip electrode
is a component of a pacing means.
10. The percutaneous lead according to claim 1, wherein said elongated body
member is a torque-controlled catheter that is substantially
non-compressable in an axial direction and moderately bendable in a
generally transverse direction. |
|
|
|
|
Claims  |
|
|
Description  |
|
|
BACKGROUND AND DESCRIPTION OF THE INVENTION
This invention generally relates to percutaneous leads for performing one
or more of mapping pacing, or ablation, the percutaneous lead being
particularly well suited for performing these functions in association
with the treatment of cardiac conditions, and it lends itself particularly
well for use as a disposable, temporary treatment device.
While the lead is substantially isodiametric when it is being passed
through a narrow body passageway such as a vein or an artery, the distal
end portion of the percutaneous lead preferably includes a plurality of
elongated slits that are spaced from each other around the circumference
of the distal end portion in order to define at least one elongated
peripheral segment having an electrode, which elongated peripheral segment
is adjustable to the extent that it folds substantially upon itself in
order to generally radially move its electrode outwardly. This
adjustability feature of the device is such that the elongated slit and
its electrode are readily returned to an orientation that is substantially
isodiametric with the remainder of the percutaneous lead. When desired, a
plurality of such adjustable elongated peripheral segments are provided.
Electrophysiological studies and treatments of patients have in the past
utilized many different devices and systems, including those that
incorporate the use of an elongated percutaneous lead that provides an
electrically conductive elongated pathway between a location that is
external of the patient and a location within the patient at which
sensing, stimulation or treatment is to take place. When this percutaneous
route is taken in conjunction with studies or treatment of the heart, this
is known as an endocardial approach. While an epicardial approach is
possible, this is not always the most suitable procedure since it requires
thoracotomy and the exposure of the heart.
When the study or treatment to be performed includes mapping and/or
ablation, such procedures require accurate identification of the focus or
foci by recording the electrical signals generated by the cardiac tissue
at specific locations. Once identified, each focus is ablated or
fulgurated. It is highly desireable, if not mandatory, to ablate the
abnormal source in an accurately circumscribed location in order to
minimize damage to normal tissue that is adjacent to the area of the
anomalous tissue. Often, such accurate location is substantially enhanced
when the epicardial approach is used rather then the substantially less
intrusive endocardial approach.
Accordingly, there is a need for a device that has the attributes of the
less intrusive endocardial approach while still providing substantial
control and adjustability on the order of that possible by the epicardial
approach so that the endocardial approach is more feasible for studies and
treatments including those involving any or all of mapping, destruction,
or pacing functions.
With more particular reference to these functions, the pacing function is
well-known in the art, whereby an electrical impulse is imparted to a
particular location of the body in order to either assist proper
functioning of a body organ or in order to control or bring under control
an iatrogenic or spontaneous dysrhythmia by pacing a ventrical or in order
to stimulate or pace the heart so as to assist in mapping its electrical
pathways. Currently available so-called pacing leads can accomplish these
functions in an endocardial manner by receiving appropriate impulses from
a pacer device that is external of the body. Typically, these devices are
capable of performing only this pacing function.
Regarding the mapping function, such is undertaken to identify specific
foci or anatomical locations which, for example, are a source of abnormal
cardiac rhythm in patients with dysrhythmias. Mapping electrode sets for
epicardial or endocardial mapping of heart signals have been provided in
the past. Typically, these mapping electrode sets are utilized during
cardiac surgery in order to sense the cardiac signal and report it to the
surgical team through appropriate display and/or print out devices. The
surgical team may observe the reported data and immediately utilize same
in connection with a surgical procedure, or the data may be collected for
subsequent analysis. Such mapping involves timing that is based upon the
leading edge of an excitation wave through conductive tissue, such as that
of the heart. Generally, mapping procedures include the induction of
tachycardia while the mapping electrode set is in place, which means that
mapping speed and efficiency are important during these procedures.
The ablation function is typically performed in association with the
mapping function. Once the specific foci or anatomical locations are
pinpointed by mapping or the like, each such location can be subjected to
ablation or fulguration in order to, in effect, destroy the target focus
or location, which for example, is the source of an abnormal cardiac
rhythm. Unless the ablation function is carried out in close association
with the mapping function, it is exceedingly difficult to achieve the
ablation accuracy which is necessary to avoid or minimize damage to normal
or undiseased tissue that is adjacent to the anomalous, damaged or
diseased tissue to be destroyed by the ablation procedure.
When one attempts to carry out the mapping function and/or the ablation
function by an endocardial approach, mapping accuracy, speed and
efficiency are typically quite difficult to achieve since the mapping
device must pass through a narrow body passageway such as a vein or an
artery. Often, electrodes of a device for carrying out endocardial mapping
provide mapping electrodes that are generally stationarily mounted with
respect to each other, whereby it is difficult to substantially modify the
mapping surface, a situation that is further complicated by the
requirement of fluoroscopic guidance for placement of mapping electrodes
and, for that matter, of the ablation tip of an endocardial ablation
device or catheter.
Another exceptionally desirable feature for a mapping device is to provide
it with an electrode array by which the electrodes of the array can
simultaneously engage the surface being mapped. When the endocardial
approach is undertaken, the surfaces being mapped usually will be concave
or generally flat. Unless the electrodes of the mapping electrode set
exhibit some degree of adjustability, it is not possible to have the same
device map such a variety of surface configurations. This type of
adjustability is rendered more difficult when such must be provided for an
endocardial device which, ideally, should be substantially isodiametric
throughout the length of the device.
There is accordingly a need for a device that can achieve endocardial
mapping or other percutaneous procedures, which device is a substantially
isodiametric catheter-type of device that has a distal end portion having
an electrode that is location-adjustable when the device is at or near its
percutaneous target location, which adjustment is carried out by
manipulation of a suitable assembly that is external of the body.
These various desirable attributes are achieved by the present invention,
which provides a percutaneous lead having an elongated body and an
elongated shaft slideably mounted within the body, with the respective
distal end portions of the elongated body and of the elongated shaft being
operatively connected to each other. The distal end portion of the
elongated body is substantially isodiametric with the rest of the body and
has a plurality of elongated slits that are spaced from each other along
the circumference of the distal end portion of the body in order to define
at least one elongated peripheral segment of the body distal end portion.
An electrode is positioned on the elongated peripheral segment. When the
elongated body and/or the elongated shaft are slidingly moved with respect
to the other, which relative movement includes either or both of movement
of the body in a distal direction or movement of the shaft in a proximal
direction, the elongated peripheral segment generally folds onto itself in
a substantially outwardly directed manner to thereby move the electrode
thereof to a location that is no longer isodiametric with respect to the
elongated body. Relative movement of the elongated body and/or elongated
shaft in substantially opposite directions returns the elongated
peripheral segment and its electrode to its initial, substantially
isodiametric configuration.
It is accordingly a general object of the present invention to provide an
improved percutaneous lead that exhibits adjustability between
isodiametric and outwardly extending electrode configurations.
Another object of the present invention is to provide an improved
percutaneous lead that is capable of performing mapping, ablation and/or
pacing without having to remove the lead from its percutaneous location.
Another object of this invention is to provide an improved percutaneous
lead that functions in the manner of an endocardial catheter that can be
guided through a narrow body passageway such as a vein or an artery when
it has a substantially isodiametric configuration but which can, after it
has been properly positioned within the body, be manipulated such that
distal electrodes thereof expand radially outwardly.
Another object of this invention is to provide a torque-controlled
temporary pervenous lead having recording electrodes for mapping of
endocardial electrophysiological signals, having electrodes for unipolar
or bypolar pacing, and having ablating capabilities.
Another object of the present invention is to provide an endocardial lead
having a multiple electrode array for mapping plane or concave internal
surfaces.
Another object of this invention is to provide an endocardial mapping lead
that has an electrode array for precise location of the ablation
electrodes and by also recording from a central or tip electrode in order
to permit identification of excitation propagation.
Another object of this invention is to provide an improved percutaneous
lead that is a relatively inexpensive and disposable.
Another object of the present invention is to provide an improved
percutaneous lead having laser-conducted ablation.
These and other objects, features and advantages of this invention will be
clearly understood through a consideration of the following detailed
description.
BRIEF DESCRIPTION OF THE DRAWINGS
In the course of this description reference will be made to the
accompanying drawings wherein:
FIG. 1 is an elevational view, partially broken away, of the percutaneous
lead according to this invention;
FIG. 2 is an elongated substantially cross-sectional view through a
percutaneous lead according to this invention such as that illustrated in
FIG. 1;
FIG. 3 is a detailed view of the distal end portion of the device shown in
FIG. 2 that is at a configuration for mapping a concave endocardial
surface;
FIG. 4 is a detailed view of the distal end portion of the device shown in
FIG. 2 that is at a configuration for mapping a substantially planar
endocardial surface;
FIG. 5 is a distal end view of the device at its orientation that is
illustrated in FIG. 3;
FIG. 6 is a distal end view of the device at its orientation that is
illustrated in FIG. 4; and
FIG. 7 is a broken-away generally cross-sectional view of an alternative
embodiment incorporating laser-conducted ablation.
DESCRIPTION OF THE PARTICULAR EMBODIMENTS
Percutaneous lead, generally designated as 21 in FIG. 1, includes an
elongated body 22 that is substantially isodiametric throughout its length
and which includes a distal end portion, generally designated as 23. An
elongated shaft 24 is positioned within a hollow core 25 of the elongated
body 22. Distal end portion 26 of the elongated shaft 24 is operatively
attached to the distal end portion 23 of the elongated body 22, while the
proximal end portion of the elongated shaft 24 has a handle assembly 27
secured thereto in order to facilitate relative movement between the
elongated shaft 24 and the elongated body 22. A locking assembly 28 can be
provided in order to fix the location of the elongated shaft 24 with
respect to the elongated body 22 after such relative movement has been
carried out. A hub 29 may be fused to the proximal end of the elongated
body 22.
In order to most advantageously impart percutaneous properties to the lead
21, the elongated body 22 may be in the nature of a torque-controlled
catheter so as to facilitate and assist in directing passage of the
percutaneous lead 21 through a body cavity such as a vein or an artery.
Additionally, the elongated shaft 24 can assist in provided
torque-controlled properties to the percutaneous lead 21 by being made of
a material and by being sized such that the elongated shaft 24 is
substantially non-compressable in an axial direction while being
moderately bendable in a generally transverse direction.
With more particular reference to the distal end portion 23 of the
elongated body 22, such includes a plurality of elongated longitudinal
slits 31 that are spaced from each other along the circumference of the
distal end portion 23 in order to thereby define at least one elongated
peripheral segment 32. An electrode 33 is mounted within or on each
elongated peripheral segment 32, and each such electrode 33 is in
electrical communication with a terminal assembly 34 projecting from the
proximal end portion of the elongated body 22. In the preferred
arrangement illustrated, this electrical communication is provided by a
multifilar coil 35 of insulated stainless steel wire or the like. Also
according to the preferred structure, each electrode 33 is formed by
stripping away the insulation of a strand of the coil 35 and having that
stripped-away portion project through one or more holes 36 through each
elongated peripheral segment 32. Each of the terminal assemblies 34 is
adapted for interconnecting to a suitable recording device (not shown).
In the embodiment illustrated in FIG. 2, a tip electrode 37 is mounted at
the distal end of the elongated body 22. A tip electrode at 37 includes an
internal stem 38 for attachment to the distal end portion 26 of the
elongated shaft 24, which in this embodiment is an electrically conductive
member such as a stainless steel wire. A seal 39 is preferably provided in
order to substantially prevent leakage around the tip electrode 37. A
terminal assembly 41 is included at the proximal end of the elongated
shaft 24 for ease of connection to the mapping recording instrument (not
shown) or to a fulgurating device such an electrocautery device (not
shown). In this embodiment, the elongated shaft 24 is a conductive wire
which, along with the tip electrode 37, are designed to withstand the
delivery of 400 Joules of electrical energy from a suitable device (not
shown) and into the tissue without loss of material or function.
Locking assembly 28 can be of known construction, such as that of a Touhy
Borst adaptor. The device illustrated in FIG. 2 includes a hub 42 having
an externally threaded portion that is fitted with a rotatable collar 43
that engages an internal grommet 44 which frictionally engages and grips
the elongated shaft 24 upon rotation of the collar 43 with respect to the
hub 42. Collar 43 abuts against the proximal end of the elongated body 22
and/or its hub 29 in order to prevent further movement of the elongated
shaft 24 into hollow core 25 of the elongated body 22.
When the elongated shaft 24 and/or the elongated body 22 are moved relative
to each other, each elongated peripheral segment 32 is modified in its
configuration. With the lead 21 in the configuration illustrated in FIG.
1, each elongated peripheral segment 32 is substantially isodiametric with
the rest of the elongated body 22. Effecting such relative movement until
an additional length of elongated shaft 24 projects beyond the proximal
end of the elongated body 22 causes each elongated peripheral segment 32
to buckle or fold onto itself and develop a generally outwardly directed
radial movement thereof and of the electrode 33 supported thereby. Such
movement to the mapping orientation illustrated in FIGS. 2, 3 and 5 is
especially appropriate for mapping a concave configuration such as that of
the cardiac cavity 45 shown in FIG. 3.
Continued relative movement of the elongated body 22 and the elongated
shaft 24 so as to proceed with additional movement of the elongated shaft
24 out of the elongated body 22 results in a mapping configuration such as
that illustrated in FIGS. 4 and 6, which is particularly suitable for
mapping generally planar surfaces 46 as shown in FIG. 4. Achieving the
configuration shown in FIG. 4 can be facilitated by positioning each
electrode 33 along the elongated peripheral segment 32 at a location that
is not centrally located on the elongated peripheral segment 32, but is at
a location distal thereof.
Distal end portion 23 may further include a ring electrode 47. Electrode 47
is in electrical communication with a suitable conductor such as a wire of
the multifilar coil 35 which is in electrical communication with a
terminal assembly 48 for connection to a suitable device, which may be
either the recording device (not shown) or the electrocautery device (not
shown) discussed hereinabove.
In the preferred arrangement illustrated in the drawings, the percutaneous
lead 21 includes four elongated peripheral segments 32 and four respective
electrodes 33 which are substantially equally circumferentially spaced
apart and which are generally equidistant from the distal tip electrode 37
and/or the ring electrode 47. These four electrodes are sensing or mapping
electrodes, and they provide a mapping electrode array.
In the embodiment illustrated in FIG. 7, the ablation capabilities are
provided by a system incorporating the use of laser energy. In this
embodiment, the elongated shaft is an optical fiber 54 that passes through
an axial bore of a tip electrode 57. Laser energy is transmitted through
the optical fiber 54 by way of a terminal 55 for connection to a laser
device (not shown), and the optical fiber 54 transmits this laser energy
therethrough and to an ablation surface 56 thereof. The tip electrode 57
is connected to a suitable terminal assembly 58 by means of a conductor or
wire 59.
Exemplary operation and use of the percutaneous lead 21 according to this
invention includes subcutaneous introduction into a vein for advancement
to the right ventricle or to the right atrium of the heart of a cardiac
patient. Advancement through an artery would be needed for placement into
the left ventricle. During such advancement procedure, the lead 21 will be
in its isodiametric configuration such as that illustrated in FIG. 1, and
gross positioning of the lead 21 to near the desired site is accomplished
by fluoroscopy. Fine positioning of the lead is accomplished by sensing
the electrical potential at each electrode 33, typically in association
with either the tip electrode 37 or the ring electrode at 47 as a
reference.
When the general area of interest is located, the elongated shaft 24 and
the elongated body 22 are moved relative to each other such that the
elongated shaft increases in its projection beyond the proximal end of the
elongated body 22, at which time each elongated peripheral segment 32
buckles onto itself until the desired degree of angulation of the segment
32 is achieved and until each electrode 33 is radially extended and
positioned as desired. After the desired position is achieved, the locking
assembly 28 may be manipulated in order to maintain that positioning.
Typically, a suitable electrode array will be formed and can be moved from
one endocardial site to another until each abnormal focus is located. Once
this focus is located by this mapping procedure, it can be ablated by the
passage of a fulgurating current through the elongated shaft 24 and to the
tip electrode 37, or, when the embodiment of FIG. 7 is utilized, the
abnormal focus can be ablated by use of a laser power source through the
optical fiber 54 and its ablation surface 56.
In sensing or mapping of the endocardial surface in this example, the array
of electrodes 33 and the tip electrode 37 can be utilized to provide a
configuration of five seperate recording, mapping or sensing sites, with
four of them forming a square and the fifth being the center point. In
addition, various combinations of pairs can be achieved utilizing these
five electrodes to determine the direction of propagation of the
electrical activity and the activation sequence of the cardiac tissue
under study. Terminal assemblies 34, 41 and 48 are connected to recording
or display instrumentation in the sequence needed to display either from
single electrodes 33 referenced to ring electrode 47 or from chosen pairs
of electrodes. If it is found necessary either to control a dysrythmia by
pacing or to stimulate the ventricles, the tip electrode 37 and the ring
electrode 47 can be utilized as a bipolar electrode configuration. Lead 21
can also be utilized in the unipolar configuration by disconnecting the
ring electrode 47 from the external pacing unit and substituting an
electrode on the elongated body 22 as an anode, which must be connected to
the other pole of an external pacer (not shown).
It will be understood that the embodiments of the present invention which
have been described are illustrative of some of the applications of the
principles of the present invention. Numerous modifications may be made by
those skilled in the art without departing from the true spirit and scope
of the invention.
* * * * *
|
|
|
|
|
Description  |
|